Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: Systematic review of the literature

Lisa L. Liu, Marcus Skribek, Ulrika Harmenberg, Marco Gerling
doi: https://doi.org/10.1101/2022.07.28.22278028

Article Information

doi 
https://doi.org/10.1101/2022.07.28.22278028
History 
  • July 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Lisa L. Liu1,2,#,
  2. Marcus Skribek1,2,
  3. Ulrika Harmenberg1,2 and
  4. Marco Gerling1,3,#
  1. 1Theme Cancer, Karolinska University Hospital, 17176 Solna, Sweden
  2. 2Department of Oncology-Pathology, Karolinska Institutet, 17176 Solna, Sweden
  3. 3Department of Bioscience and Nutrition, Karolinska Institutet, 14183 Huddinge, Sweden
  1. ↵#Corresponding authors: Lisa L. Liu Burström, MD, PhD, email: lisa.liu{at}ki.se, Marco Gerling, Dr. med, email: marco.gerling{at}ki.se
Back to top
Posted July 30, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: Systematic review of the literature
Lisa L. Liu, Marcus Skribek, Ulrika Harmenberg, Marco Gerling
medRxiv 2022.07.28.22278028; doi: https://doi.org/10.1101/2022.07.28.22278028
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area